Phage therapy specialist Vésale Bioscience gas bageds €1.8m from European Innovation Council (EIC) to fight antibiotic resistance (AMR). Under the grant provided by the EIC Accelerator Fund for the PhageDiag project, Belgian Vésale Bioscience BV (Namur) will develop a phage therapy diagnostic platform to fight multidrug-resistant infections. Within the PhageDiag project, a phagogram using artificial intelligence will be developed that enables decentralized diagnostics and personalized treatment of bacterial infections.
The EIC Accelerator jury said the project can provide a clear diagnosis “that allows a personalized phage treatment which potentially gives a higher rate of success.” PhageDiag, is a fast and user-friendly diagnostic technology, or phagogram, for personalized phage therapy. It is the first automated in vitro diagnostic tool to quickly determine suitable bacteriophages for treating a particular bacterial infection.